Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Definium Therapeutics, Inc. (DFTX), most recent 12 months reported: net loss $353.79M. Latest balance sheet on file: liquid cash $1.08B, total debt $36.47M, net cash $1.05B. From SEC filings. More on Definium Therapeutics, Inc.: Profitability · Debt Others in Medicinal Chemicals & Botanical Products: Cordyceps Sunshine Biotech Holdings Co., Ltd. · ADIA NUTRITION, INC. · China Foods Holdings Ltd. · NUTRA PHARMA CORP. · AIBOTICS, INC. · Raphael Pharmaceutical Inc. · REGENCELL BIOSCIENCE HOLDINGS LIMITED · The Cannaisseur Group, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.